L. Barone

发表

Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.

A. Monks, K. Tew, L. Barone, 1996, Molecular pharmacology.

An Orally Bioavailable Antipoxvirus Compound (ST-246) Inhibits Extracellular Virus Formation and Protects Mice from Lethal Orthopoxvirus Challenge

R. Jordan, R. Baker, R. Buller, 2005, Journal of Virology.

P-glycoprotein binding and modulation of the multidrug-resistant phenotype by estramustine.

K. Tew, G. Hudes, C. Smith, 1994, Journal of the National Cancer Institute.

Combined antimicrotubule activity of estramustine and taxol in human prostatic carcinoma cell lines.

K. Tew, L. Barone, L. Speicher, 1992, Cancer research.

Amplification of the ATP-binding cassette 2 transporter gene is functionally linked with enhanced efflux of estramustine in ovarian carcinoma cells.

D. Bell, J. Testa, K. Tew, 1998, Cancer research.

Relationship of Pleconaril Susceptibility and Clinical Outcomes in Treatment of Common Colds Caused by Rhinoviruses

F. Hayden, M. Collett, D. Pevear, 2005, Antimicrobial Agents and Chemotherapy.

Interaction of an estramustine photoaffinity analogue with cytoskeletal proteins in prostate carcinoma cells.

K. Tew, K. Seamon, L. Barone, 1994, Molecular pharmacology.

Validation of an in vitro screen for phospholipidosis using a high-content biology platform

Y-K Lee, F. Pognan, R. Vrzal, 2006, Cell Biology and Toxicology.

Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4+ and CD8+ T Cells

S. Santulli-Marotto, B. Harman, L. Barone, 2016, Front. Immunol..

Epitope‐dependent mechanisms of CD27 neutralization revealed by X‐ray crystallography

G. Gilliland, A. Teplyakov, G. Obmolova, 2017, Molecular immunology.

Phospholipogenic Pharmaceuticals Are Associated with a Higher Incidence of Histological Findings than Nonphospholipogenic Pharmaceuticals in Preclinical Toxicology Studies

Scott Boyer, S. Boyer, J. Fikes, 2012, Journal of toxicology.